Rationale and Development of a Data Coordinating Center to Support the Type 1 Diabetes in Acute Pancreatitis Consortium.

Autor:	Dyer AM; From the Department of Public Health Sciences., Baab KT; From the Department of Public Health Sciences., Merchlinski A; From the Department of Public Health Sciences., Valencia-Moulton PA; From the Department of Public Health Sciences., Holmes BR; From the Department of Public Health Sciences., Pichardo-Lowden A; Division of Endocrinology, Diabetes and Metabolism, Penn State Health, Penn State College of Medicine, Hershey, PA., Serrano J; Divisions of Digestive Diseases and Nutrition., Laughlin MR; Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD., Chinchilli VM; From the Department of Public Health Sciences.
Jazyk:	angličtina
Zdroj:	Pancreas [Pancreas] 2022 Jul 01; Vol. 51 (6), pp. 604-607.
DOI:	10.1097/MPA.0000000000002075
Abstrakt:	Abstract: A data coordinating center (DCC) is a critical member of any multicenter research undertaking, and that is especially true for the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC). We describe how the T1DAPC DCC supports the consortium via its experience and expertise in project management, administration, financial management, regulatory compliance, scientific coordination, data management, research computing, and biostatistics and in facilitating scientific publications. The DCC's matrix management system has been extremely effective in managing all of its responsibilities. The first 16 months in the life of the T1DAPC have been dedicated to the development of its first protocol, titled Diabetes RElated to Acute pancreatitis and its Mechanisms (DREAM), addressing the institutional review board and regulatory components, developing the T1DAPC data management system, and providing training and certification of clinical center staff. As a result of its efforts, the DCC was a major contributor to the T1DAPC being able to initiate recruitment for the DREAM study in January 2022. Competing Interests: The authors declare no conflict of interest. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu